Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Split-Window OCT biometry in pseudophakic eyes. | Acta Ophthalmol | 2022 | 35670319 | PubTator, text mining | PubMed |
| Machine learning OCT predictors of progression from intermediate age-related macular degeneration to geographic atrophy and vision loss. | Ophthalmol Sci | 2022 | 35662803 | PubTator, text mining | PubMed |
| Relationship Quality and Health Among Black Same-Sex Male Couples: Protocol for a Symbolic Netnography Study. | JMIR Res Protoc | 2022 | 35657652 | PubTator, text mining | PubMed |
| Pascal short-pulse plus subthreshold endpoint management laser therapy for diabetic macular edema: the "sandwich technique". | Int J Retina Vitreous | 2022 | 35655248 | PubTator, text mining | PubMed |
| Bacillary Detachment in Neovascular Age-Related Macular Degeneration: Incidence, Clinical Features, and Response to Anti-VEGF Therapy. | Ophthalmol Retina | 2022 | 35654365 | PubTator, text mining | PubMed |
| Vitrectomy with arteriotomy and neurotomy in retinal artery occlusion - A case series. | Indian J Ophthalmol | 2022 | 35647985 | PubTator, text mining | PubMed |
| Filgotinib: A Clinical Pharmacology Review. | Clin Pharmacokinet | 2022 | 35637376 | PubTator, text mining | PubMed |
| Interleaved Optical Coherence Tomography: Clinical and Laboratory Biomarkers in Patients with Diabetic Macular Edema. | J Pers Med | 2022 | 35629188 | PubTator, text mining | PubMed |
| A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression. | Int J Mol Sci | 2022 | 35628442 | PubTator, text mining | PubMed |
| Combining Optical Coherence Tomography and Fundus Photography to Improve Glaucoma Screening. | Diagnostics (Basel) | 2022 | 35626256 | PubTator, text mining | PubMed |
| Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single-Cell Resolution using a Microfluidic Tumor Microenvironment Model. | Adv Sci (Weinh) | 2022 | 35619544 | PubTator, text mining | PubMed |
| Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes. | BMC Endocr Disord | 2022 | 35619086 | PubTator, text mining | PubMed |
| The macular inner plexiform layer thickness as an early diagnostic indicator for Parkinson's disease. | NPJ Parkinsons Dis | 2022 | 35614125 | PubTator, text mining | PubMed |
| The Hippo pathway mediates Semaphorin signaling. | Sci Adv | 2022 | 35613278 | PubTator, text mining | PubMed |
| Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature. | Arch Endocrinol Metab | 2022 | 35612842 | PubTator, text mining | PubMed |
| Adaptive optics ophthalmoscopy in retinitis pigmentosa (RP): Typical patterns. | Acta Ophthalmol | 2022 | 35611574 | PubTator, text mining | PubMed |
| Drug Distribution in Brain and Cerebrospinal Fluids in Relation to IC50 Values in Aging and Alzheimer's Disease, Using the Physiologically Based LeiCNS-PK3.0 Model. | Pharm Res | 2022 | 35606598 | PubTator, text mining | PubMed |
| Multipressure Dial Goggle Effects on Circumpapillary Structure and Microvasculature in Glaucoma Patients. | Ophthalmol Glaucoma | 2022 | 35605936 | PubTator, text mining | PubMed |
| Retinal microcirculation characteristics in obstructive sleep apnea/hypopnea syndrome evaluated by OCT-angiography: a literature review. | Int Ophthalmol | 2022 | 35604623 | PubTator, text mining | PubMed |
| In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions. | Pharmacol Res Perspect | 2022 | 35599347 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=50